251 related articles for article (PubMed ID: 16204663)
1. Somatic acquisition and signaling of TGFBR1*6A in cancer.
Pasche B; Knobloch TJ; Bian Y; Liu J; Phukan S; Rosman D; Kaklamani V; Baddi L; Siddiqui FS; Frankel W; Prior TW; Schuller DE; Agrawal A; Lang J; Dolan ME; Vokes EE; Lane WS; Huang CC; Caldes T; Di Cristofano A; Hampel H; Nilsson I; von Heijne G; Fodde R; Murty VV; de la Chapelle A; Weghorst CM
JAMA; 2005 Oct; 294(13):1634-46. PubMed ID: 16204663
[TBL] [Abstract][Full Text] [Related]
2. Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development.
Bian Y; Knobloch TJ; Sadim M; Kaklamani V; Raji A; Yang GY; Weghorst CM; Pasche B
Hum Mol Genet; 2007 Dec; 16(24):3128-35. PubMed ID: 17890272
[TBL] [Abstract][Full Text] [Related]
3. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
Kaklamani VG; Baddi L; Liu J; Rosman D; Phukan S; Bradley C; Hegarty C; McDaniel B; Rademaker A; Oddoux C; Ostrer H; Michel LS; Huang H; Chen Y; Ahsan H; Offit K; Pasche B
Cancer Res; 2005 Apr; 65(8):3454-61. PubMed ID: 15833881
[TBL] [Abstract][Full Text] [Related]
4. The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study.
Castillejo A; Mata-Balaguer T; Montenegro P; Ochoa E; Lázaro R; Martínez-Cantó A; Castillejo MI; Guarinos C; Barberá VM; Guillén-Ponce C; Carrato A; Soto JL
BMC Cancer; 2009 Jun; 9():193. PubMed ID: 19538729
[TBL] [Abstract][Full Text] [Related]
5. TGFBR1*6A is a potential modifier of migration and invasion in colorectal cancer cells.
Zhou R; Huang Y; Cheng B; Wang Y; Xiong B
Oncol Lett; 2018 Mar; 15(3):3971-3976. PubMed ID: 29467907
[TBL] [Abstract][Full Text] [Related]
6. TGFBR1*6A enhances the migration and invasion of MCF-7 breast cancer cells through RhoA activation.
Rosman DS; Phukan S; Huang CC; Pasche B
Cancer Res; 2008 Mar; 68(5):1319-28. PubMed ID: 18316594
[TBL] [Abstract][Full Text] [Related]
7. Int7G24A variant of transforming growth factor-beta receptor type I is associated with invasive breast cancer.
Chen T; Jackson CR; Link A; Markey MP; Colligan BM; Douglass LE; Pemberton JO; Deddens JA; Graff JR; Carter JH
Clin Cancer Res; 2006 Jan; 12(2):392-7. PubMed ID: 16428477
[TBL] [Abstract][Full Text] [Related]
8. Lack of an association between the TGFBR1*6A variant and colorectal cancer risk.
Skoglund J; Song B; Dalén J; Dedorson S; Edler D; Hjern F; Holm J; Lenander C; Lindforss U; Lundqvist N; Olivecrona H; Olsson L; Påhlman L; Rutegård J; Smedh K; Törnqvist A; Houlston RS; Lindblom A
Clin Cancer Res; 2007 Jun; 13(12):3748-52. PubMed ID: 17575241
[TBL] [Abstract][Full Text] [Related]
9. Role of TGF-beta in cancer and the potential for therapy and prevention.
Kaklamani VG; Pasche B
Expert Rev Anticancer Ther; 2004 Aug; 4(4):649-61. PubMed ID: 15270668
[TBL] [Abstract][Full Text] [Related]
10. TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies.
Kaklamani VG; Hou N; Bian Y; Reich J; Offit K; Michel LS; Rubinstein WS; Rademaker A; Pasche B
J Clin Oncol; 2003 Sep; 21(17):3236-43. PubMed ID: 12947057
[TBL] [Abstract][Full Text] [Related]
11. TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer.
Song B; Margolin S; Skoglund J; Zhou X; Rantala J; Picelli S; Werelius B; Lindblom A
Br J Cancer; 2007 Oct; 97(8):1175-9. PubMed ID: 17848956
[TBL] [Abstract][Full Text] [Related]
12. No major association between TGFBR1*6A and prostate cancer.
Kaklamani V; Baddi L; Rosman D; Liu J; Ellis N; Oddoux C; Ostrer H; Chen Y; Ahsan H; Offit K; Pasche B
BMC Genet; 2004 Sep; 5():28. PubMed ID: 15385056
[TBL] [Abstract][Full Text] [Related]
13. TbetaR-I(6A) is a candidate tumor susceptibility allele.
Pasche B; Kolachana P; Nafa K; Satagopan J; Chen YG; Lo RS; Brener D; Yang D; Kirstein L; Oddoux C; Ostrer H; Vineis P; Varesco L; Jhanwar S; Luzzatto L; Massagué J; Offit K
Cancer Res; 1999 Nov; 59(22):5678-82. PubMed ID: 10582683
[TBL] [Abstract][Full Text] [Related]
14. TGFBR1 and cancer susceptibility.
Pasche B; Pennison MJ; Jimenez H; Wang M
Trans Am Clin Climatol Assoc; 2014; 125():300-12. PubMed ID: 25125747
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms and haplotype structures in genes for transforming growth factor beta1 and its receptors in familial and unselected breast cancers.
Jin Q; Hemminki K; Grzybowska E; Klaes R; Söderberg M; Zientek H; Rogozinska-Szczepka J; Utracka-Hutka B; Pamula J; Pekala W; Försti A
Int J Cancer; 2004 Oct; 112(1):94-9. PubMed ID: 15305380
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancers in patients with the (9A/6A) polymorphism of TGFBR1 exhibit lesser inter-(simple sequence repeat) PCR genomic instability and present clinically at greater age.
Dutt SS; Chen N; Darbary HK; Swede H; Petrelli NJ; Stoler DL; Anderson GR
Mutat Res; 2008 Oct; 645(1-2):27-32. PubMed ID: 18778720
[TBL] [Abstract][Full Text] [Related]
17. Is TGFBR1*6A a susceptibility allele for nonsyndromic familial colorectal neoplasia?
Daley D; Morgan W; Lewis S; Willis J; Elston RC; Markowitz SD; Wiesner GL
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):892-4. PubMed ID: 17507611
[TBL] [Abstract][Full Text] [Related]
18. Transforming Growth Factor β Signaling in Colorectal Cancer Cells With Microsatellite Instability Despite Biallelic Mutations in TGFBR2.
de Miranda NF; van Dinther M; van den Akker BE; van Wezel T; ten Dijke P; Morreau H
Gastroenterology; 2015 Jun; 148(7):1427-37.e8. PubMed ID: 25736321
[TBL] [Abstract][Full Text] [Related]
19. Novel inactivating mutations of transforming growth factor-beta type I receptor gene in head-and-neck cancer metastases.
Chen T; Yan W; Wells RG; Rimm DL; McNiff J; Leffell D; Reiss M
Int J Cancer; 2001 Sep; 93(5):653-61. PubMed ID: 11477574
[TBL] [Abstract][Full Text] [Related]
20. The S387Y mutations of the transforming growth factor-beta receptor type I gene is uncommon in metastases of breast cancer and other common types of adenocarcinoma.
Anbazhagan R; Bornman DM; Johnston JC; Westra WH; Gabrielson E
Cancer Res; 1999 Jul; 59(14):3363-4. PubMed ID: 10416594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
